vs
DULUTH HOLDINGS INC.（DLTH）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是DULUTH HOLDINGS INC.的1.7倍（$197.9M vs $114.9M），REPLIGEN CORP净利率更高（6.7% vs -8.8%，领先15.5%），REPLIGEN CORP同比增速更快（13.6% vs -9.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $-8.9M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -31.6%）
德卢思控股是一家美国工装及配饰企业，主打通过旗下德卢思贸易品牌开展产品销售业务，面向市场推出各类实用工装及相关配饰产品，是美国本土颇具特色的服饰零售企业。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
DLTH vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$114.9M
营收增速更快
RGEN
高出23.2%
-9.6%
净利率更高
RGEN
高出15.5%
-8.8%
自由现金流更多
RGEN
多$26.5M
$-8.9M
两年增速更快
RGEN
近两年复合增速
-31.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.9M | $197.9M |
| 净利润 | $-10.1M | $13.3M |
| 毛利率 | 53.8% | 52.5% |
| 营业利润率 | -7.7% | 9.0% |
| 净利率 | -8.8% | 6.7% |
| 营收同比 | -9.6% | 13.6% |
| 净利润同比 | 64.6% | 143.9% |
| 每股收益（稀释后） | $-0.29 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DLTHRGEN
| Q4 25 | $114.9M | $197.9M | ||
| Q3 25 | $131.7M | $188.8M | ||
| Q2 25 | $102.7M | $182.4M | ||
| Q1 25 | $241.3M | $169.2M | ||
| Q4 24 | $127.1M | $174.1M | ||
| Q3 24 | $141.6M | $154.9M | ||
| Q2 24 | $116.7M | $154.1M | ||
| Q1 24 | $245.6M | $151.3M |
净利润DLTHRGEN
| Q4 25 | $-10.1M | $13.3M | ||
| Q3 25 | $1.3M | $14.9M | ||
| Q2 25 | $-15.3M | $14.9M | ||
| Q1 25 | $-5.6M | $5.8M | ||
| Q4 24 | $-28.2M | $-30.3M | ||
| Q3 24 | $-2.0M | $-654.0K | ||
| Q2 24 | $-7.9M | $3.3M | ||
| Q1 24 | $6.4M | $2.1M |
毛利率DLTHRGEN
| Q4 25 | 53.8% | 52.5% | ||
| Q3 25 | 54.7% | 53.2% | ||
| Q2 25 | 52.0% | 50.0% | ||
| Q1 25 | 44.1% | 53.6% | ||
| Q4 24 | 52.3% | 26.1% | ||
| Q3 24 | 52.3% | 50.0% | ||
| Q2 24 | 52.8% | 49.8% | ||
| Q1 24 | 48.2% | 49.5% |
营业利润率DLTHRGEN
| Q4 25 | -7.7% | 9.0% | ||
| Q3 25 | 1.8% | 8.9% | ||
| Q2 25 | -12.0% | 7.6% | ||
| Q1 25 | -1.8% | 3.9% | ||
| Q4 24 | -17.4% | -17.7% | ||
| Q3 24 | -1.1% | -5.1% | ||
| Q2 24 | -7.7% | 1.0% | ||
| Q1 24 | 3.6% | 1.3% |
净利率DLTHRGEN
| Q4 25 | -8.8% | 6.7% | ||
| Q3 25 | 1.0% | 7.9% | ||
| Q2 25 | -14.9% | 8.2% | ||
| Q1 25 | -2.3% | 3.4% | ||
| Q4 24 | -22.2% | -17.4% | ||
| Q3 24 | -1.4% | -0.4% | ||
| Q2 24 | -6.7% | 2.2% | ||
| Q1 24 | 2.6% | 1.4% |
每股收益（稀释后）DLTHRGEN
| Q4 25 | $-0.29 | $0.24 | ||
| Q3 25 | $0.04 | $0.26 | ||
| Q2 25 | $-0.45 | $0.26 | ||
| Q1 25 | $-0.17 | $0.10 | ||
| Q4 24 | $-0.84 | $-0.55 | ||
| Q3 24 | $-0.06 | $-0.01 | ||
| Q2 24 | $-0.24 | $0.06 | ||
| Q1 24 | $0.20 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.2M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $160.6M | $2.1B |
| 总资产 | $468.0M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资DLTHRGEN
| Q4 25 | $8.2M | $767.6M | ||
| Q3 25 | $5.7M | $748.7M | ||
| Q2 25 | $8.6M | $708.9M | ||
| Q1 25 | $3.3M | $697.2M | ||
| Q4 24 | $9.3M | $757.4M | ||
| Q3 24 | $9.8M | $784.0M | ||
| Q2 24 | $6.8M | $809.1M | ||
| Q1 24 | $32.2M | $780.6M |
总债务DLTHRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DLTHRGEN
| Q4 25 | $160.6M | $2.1B | ||
| Q3 25 | $170.0M | $2.1B | ||
| Q2 25 | $167.9M | $2.1B | ||
| Q1 25 | $182.7M | $2.0B | ||
| Q4 24 | $188.1M | $2.0B | ||
| Q3 24 | $215.7M | $2.0B | ||
| Q2 24 | $218.4M | $2.0B | ||
| Q1 24 | $222.8M | $2.0B |
总资产DLTHRGEN
| Q4 25 | $468.0M | $2.9B | ||
| Q3 25 | $433.8M | $2.9B | ||
| Q2 25 | $463.7M | $2.9B | ||
| Q1 25 | $452.4M | $2.9B | ||
| Q4 24 | $533.1M | $2.8B | ||
| Q3 24 | $488.6M | $2.8B | ||
| Q2 24 | $471.4M | $2.9B | ||
| Q1 24 | $491.2M | $2.8B |
负债/权益比DLTHRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | $17.6M |
| 自由现金流率自由现金流/营收 | -7.8% | 8.9% |
| 资本支出强度资本支出/营收 | 2.0% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $1.7M | $93.9M |
8季度趋势，按日历期对齐
经营现金流DLTHRGEN
| Q4 25 | $-6.7M | $25.7M | ||
| Q3 25 | $32.0M | $48.1M | ||
| Q2 25 | $-56.5M | $28.6M | ||
| Q1 25 | $41.2M | $15.0M | ||
| Q4 24 | $-41.1M | $39.2M | ||
| Q3 24 | $16.6M | $49.3M | ||
| Q2 24 | $-33.7M | $42.2M | ||
| Q1 24 | $69.7M | $44.7M |
自由现金流DLTHRGEN
| Q4 25 | $-8.9M | $17.6M | ||
| Q3 25 | $29.8M | $43.4M | ||
| Q2 25 | $-57.8M | $21.5M | ||
| Q1 25 | $38.7M | $11.4M | ||
| Q4 24 | $-43.7M | $33.6M | ||
| Q3 24 | $15.0M | $42.3M | ||
| Q2 24 | $-35.2M | $37.4M | ||
| Q1 24 | $60.6M | $36.4M |
自由现金流率DLTHRGEN
| Q4 25 | -7.8% | 8.9% | ||
| Q3 25 | 22.6% | 23.0% | ||
| Q2 25 | -56.3% | 11.8% | ||
| Q1 25 | 16.0% | 6.8% | ||
| Q4 24 | -34.4% | 19.3% | ||
| Q3 24 | 10.6% | 27.3% | ||
| Q2 24 | -30.2% | 24.3% | ||
| Q1 24 | 24.7% | 24.0% |
资本支出强度DLTHRGEN
| Q4 25 | 2.0% | 4.1% | ||
| Q3 25 | 1.7% | 2.5% | ||
| Q2 25 | 1.3% | 3.9% | ||
| Q1 25 | 1.0% | 2.1% | ||
| Q4 24 | 2.1% | 3.2% | ||
| Q3 24 | 1.2% | 4.5% | ||
| Q2 24 | 1.3% | 3.1% | ||
| Q1 24 | 3.7% | 5.5% |
现金转化率DLTHRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 25.40× | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | 10.86× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DLTH
| Sales Channel Directly To Consumer | $67.4M | 59% |
| Sales Channel Through Intermediary | $47.4M | 41% |
RGEN
暂无分部数据
